Christopher Centeno, MDBroomfield, CO | Lone Tree, CO
Areas treated: Cervical Spine (including CCI), Elbow, Foot & Ankle, Hand & Wrist, Hip, Knee, Lumbar Spine, Other Conditions, Shoulder, Thoracic Spine
Request an AppointmentCall to Schedule Schedule Online
Christopher J. Centeno, M.D. is an international expert and specialist in regenerative medicine and the clinical use of mesenchymal stem cells in orthopedics. He is board certified in physical medicine as well as rehabilitation and in pain management through The American Board of Physical Medicine and Rehabilitation.
Dr. Centeno is one of the few physicians in the world with extensive experience in the culture expansion of and clinical use of adult stem cells to treat orthopedic injuries. His clinic incorporates a variety of revolutionary pain management techniques to bring its broad patient base relief and results. Dr. Centeno treats patients from all over the US who travel to Colorado to undergo innovative, non-surgical treatments. Dr. Centeno has chaired multiple international research based conferences. He also maintains an active research based practice, with multiple publications listed in the US National Library of Medicine. Dr. Centeno has also served as editor-in-chief of a medical research journal dedicated to traumatic injury.
He hails from both Florida and New York and currently resides in Boulder, Colorado with his wife and three children.
Florida State University; Tallahassee, Florida, Cum Laude in Chemistry
University of South Florida; Tampa, Florida
Baylor College of Medicine/The Institute for Rehab Research, Physical medicine and rehabilitation
Presbyterian/St. Luke Hospitals. Denver, Colorado
- 1993-Present-State of Colorado
- 1990-1993-State of Texas
Physical Medicine and Rehabilitation, American Academy of Physical Medicine
- Why is the Thoracic Spine a No Man’s Land? - Wed Dec 7
- The Birth Tissue Research Con - Tue Dec 6
- The Difference - Tue Dec 6
- The Use of Botox to Treat TMJ: Why This Is Yet Another Bad Idea - Sun Dec 4
- New Study Questions the Validity of Long-COVID - Sat Dec 3